BGM Group Ltd announced the resignation of Mr. Chen Xin as Chairman of the Board and Co-Chief Executive Officer, effective July 30, 2026, citing personal reasons without any dispute with the company. The board appointed his father, Mr. Zhanchang Xin, as the new Chairman of the Board, leveraging over 35 years of pharmaceutical industry experience. Additionally, Ms. Hong Li was appointed as Co-Chief Executive Officer effective July 30, 2026, bringing extensive financial management and accounting expertise from her tenure at Gansu Qilianshan Pharmaceutical Co. Ltd. These leadership changes represent a significant transition in the company's executive structure.
